First Eagle Investment Management
IRWD icon

First Eagle Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Eagle Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,104,225
Closed -$7.2M – 407
2024
Q2 		$7.2M Buy
1,104,225
+102,000
+10% +$721K 0.02% 217
2024
Q1 		$8.73M Buy
1,002,225
+95,000
+10% +$1.15M 0.02% 187
2023
Q4 		$10.4M Buy
907,225
+90,636
+11% +$897K 0.02% 137
2023
Q3 		$7.86M Buy
816,589
+226,700
+38% +$2.22M 0.02% 146
2023
Q2 		$6.28M Buy
589,889
+98,525
+20% +$1.06M 0.02% 169
2023
Q1 		$5.17M Buy
491,364
+150,834
+44% +$1.69M 0.01% 161
2022
Q4 		$4.22M Buy
340,530
+85,030
+33% +$965K 0.01% 148
2022
Q3 		$2.65M Buy
+255,500
New +$2.9M 0.01% 173

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Eagle Investment Management's IRWD Position: Q3 2024 in Review

First Eagle Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 1,104,225 shares — an estimated $7.2M sold.

First Eagle Investment Management first reported a position in IRWD in Q3 2022 and held it in 8 quarters. The position peaked at $10.4M in Q4 2023. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • First Eagle Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • First Eagle Investment Management sold 1,104,225 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $7.2M.
  • First Eagle Investment Management first reported a position in Ironwood Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • First Eagle Investment Management's Ironwood Pharmaceuticals position peaked at $10.4M in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on First Eagle Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.